| Literature DB >> 31086552 |
Jin Yong Kim1, Song Am Lee2, Jae Joon Hwang3, Jae Bum Park4, Sang Woo Park5, Yo Han Kim6, Hyeong Ju Moon7, Woo Surng Lee8.
Abstract
BACKGROUND ANDEntities:
Keywords: Angiography; Embolization; Hypovolemic Shock; Lumbar Artery; Retroperitoneal Hematoma
Year: 2019 PMID: 31086552 PMCID: PMC6500815 DOI: 10.12669/pjms.35.2.639
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Fig.1Transverse (A&B), coronal (C) and sagittal (D) enhanced abdomen and pelvis scans show a massive hematoma and extravasation of contrast dye into the retroperitoneal space. White arrow head indicates active lumbar arterial bleeding and a preformed massive hematoma in the retroperitoneal space. Seventy-two days after transcatheter arterial embolization, transverse (E&F), coronal (G) and sagittal (H) enhanced abdomen and pelvis scans show a resolving hematoma. White arrow indicates a 3.0-cmresolving hematoma in the retroperitoneal space.
Fig.2A. Angiography was performed through the right common femoral artery, a 5-Fr catheter was inserted, and the left 4th lumbar artery was selected. Initial angiogram shows dye leakage and pseudoaneurysmal change in a branch of the left lumbar artery (white arrow). B & C. Delayed angiogram of a ruptured lumbar artery branch taken after super selection with a microcatheter (1.9-Fr) shows more prominent extravasation of dye into the retroperitoneal space. White arrow indicates active dye leakage and pseudoaneurysmal change. D. Angiogram taken after embolization shows successful embolization without any dye leakage.
Systematic review of the literature massive retroperitoneal hematoma, which were caused by spontaneous lumbar artery rupture and treated with arteriographic embolization.
| Year | Reporter | No | Sex/Age | Risk factors | RRT | Tx | Mortality | COD |
|---|---|---|---|---|---|---|---|---|
| 2018 | Present case | 1 | M/92 | HTN, advanced age | None | TAE | SV | - |
| 2017 | Hwang NK et al. | 3 | M/43 | DM, LC, HTN, CRF, HDHP | HD | TAE | SV | - |
| F/69 | DM, CAD, CRF, HDHP, ASP, CLO | HD | TAE | NS | HS, MOF | |||
| M/48 | WF, PAOD, CS, CRF, HDHP, CAD, CLO, PLE, enoxaparin | PD, HD | TAE | SV | - | |||
| 2015 | Park JK et al. | 1 | M/71 | HP, DM, pulmonary edema | CRRT | TAE | SV | - |
| 2014 | Yamamura et al. | 3 | M/45 | NM, LC, s/p LT | CRRT | TAE | SV | - |
| M/63 | NM, fulminant hepatitis | CRRT | TAE | NS | MOF | |||
| F/77 | HP, post cardiac arrest syndrome, thyroid carcinoma | None | TAE | SV | - | |||
| 2011 | Surani S et al. | 1 | M/67 | ESRD on HD, DM, CAD, MVR , WF | HD | TAE | SV | - |
| 2009 | Sun PL et al. | 1 | F/73 | Enoxaparine, s/p THR | None | TAE | SV | - |
| 2007 | Fortina M et al. | 1 | M/78 | Fondaparinux, s/p THR, s/p NPT | None | TAE | SV | - |
| 2004 | Hama Y et al. | 1 | F/38 | Alcoholic LC | None | TAE | NI | - |
| 2004 | Pyo SH et al. | 1 | F/57 | CRF, HDHP, HTN, CLO | HD | TAE | NI | - |
| 2003 | Schuster F et al. | 1 | M/77 | BC, anticoagulation, s/p HVR | None | TAE | SV | - |
| 2001 | Halak M et al. | 1 | F/72 | CRF, HDHP, HTN, CHF, IHD | HD | TAE | NS | HS, MOF |
| Total | 11 reports | 15 | M/F:9/6 | 62.71 ± 13.93 | SV/NS/NI,10/3/2 | |||
No: number, RRT: Renal replacement therapy, Tx: Treatment, M: Male, F; Female,
COD: Cause of death, HD: Hemodialysis, DM: Diabetes mellitus, LC: Liver cirrhosis,
HTN: Hypertension, CRF: Chronic renal failure, HP: Heparin, HDHP: Hemodialysis with heparin,
TAE: Transcatheter arterial embolization, SV: Survival, NS: Non-survival, ASP: Aspirin,
CLO: Clopidogrel, HS: Hypovolemic shock, MOF: Multiple organ failure, PD: Peritoneal dialysis,
WF: Warfarinization, PAOD: Peripheral artery occlusive disease, CS: Cerebral stroke, CAD: Coronary artery disease, PLE: Pletaal (cilostazol), NM: Nafamostat mesilate, LT: Liver transplantation,
ESRD: End-stage renal disease, MVR: Mitral valve replacement, S/P: Status post,
THR: Total hip replacement, NPT: Nephrectomy, NI: Not identified, BC: Bladder carcinoma,
HVR: Heart valve replacement, CHF: Congestive heart failure, IHD: Ischemic heart disease,